MetLife Investment Management’s Avient AVNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.44M Buy
94,891
+795
+0.8% +$29.5K 0.02% 788
2025
Q4
$2.94M Sell
94,096
-4,986
-5% -$154K 0.01% 876
2025
Q3
$3.26M Sell
99,082
-3,596
-4% -$125K 0.02% 847
2025
Q2
$3.32M Sell
102,678
-42
-0% -$1.45K 0.02% 762
2025
Q1
$3.82M Sell
102,720
-1,692
-2% -$70K 0.02% 747
2024
Q4
$4.27M Buy
104,412
+6,716
+7% +$325K 0.02% 654
2024
Q3
$4.92M Sell
97,696
-823
-0.8% -$37.8K 0.03% 537
2024
Q2
$4.3M Buy
98,519
+3,789
+4% +$166K 0.03% 579
2024
Q1
$4.11M Sell
94,730
-2,416
-2% -$94.2K 0.03% 604
2023
Q4
$4.04M Sell
97,146
-763
-0.8% -$26.6K 0.03% 602
2023
Q3
$3.46M Buy
97,909
+783
+0.8% +$30.3K 0.03% 633
2023
Q2
$3.97M Sell
97,126
-1,043
-1% -$40.9K 0.03% 587
2023
Q1
$4.04M Sell
98,169
-1,405
-1% -$56K 0.03% 588
2022
Q4
$3.36M Sell
99,574
-1,083
-1% -$35.6K 0.03% 675
2022
Q3
$3.05M Sell
100,657
-4,096
-4% -$170K 0.03% 682
2022
Q2
$4.2M Sell
104,753
-641
-0.6% -$30.3K 0.03% 533
2022
Q1
$5.06M Buy
105,394
+30,480
+41% +$1.57M 0.03% 522
2021
Q4
$4.19M Sell
74,914
-998
-1% -$54.6K 0.03% 489
2021
Q3
$3.52M Sell
75,912
-1,759
-2% -$84.5K 0.03% 555
2021
Q2
$3.82M Sell
77,671
-3,975
-5% -$201K 0.03% 538
2021
Q1
$3.86M Sell
81,646
-5,669
-6% -$253K 0.04% 526
2020
Q4
$3.52M Sell
87,315
-5,172
-6% -$182K 0.03% 536
2020
Q3
$2.45M Sell
92,487
-1,925
-2% -$50.2K 0.03% 632
2020
Q2
$2.48M Buy
94,412
+5,454
+6% +$127K 0.03% 621
2020
Q1
$1.69M Buy
88,958
+13,281
+18% +$372K 0.02% 675
2019
Q4
$2.78M Sell
75,677
-3,281
-4% -$107K 0.03% 668
2019
Q3
$2.58M Sell
78,958
-1,392
-2% -$44.1K 0.03% 684
2019
Q2
$2.52M Sell
80,350
-1,169
-1% -$32.7K 0.03% 700
2019
Q1
$2.39M Sell
81,519
-1,291
-2% -$40.5K 0.03% 739
2018
Q4
$2.37M Sell
82,810
-270
-0.3% -$9.04K 0.03% 681
2018
Q3
$3.63M Sell
83,080
-3,903
-4% -$171K 0.04% 551
2018
Q2
$3.76M Sell
86,983
-217
-0.2% -$9.33K 0.04% 461
2018
Q1
$3.71M Sell
87,200
-647
-0.7% -$27.9K 0.04% 481
2017
Q4
$3.82M Buy
+87,847
New +$3.86M 0.04% 490

Other funds holding AVNT

MetLife Investment Management's AVNT Position: Q1 2026 in Review

MetLife Investment Management increased its Avient (AVNT) stake by 0.84% in Q1 2026, buying an estimated $29.5K and bringing the position to 94,891 shares worth $3.44M. The position accounts for 0.02% of the portfolio, ranked #788.

MetLife Investment Management first reported a position in AVNT in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.06M in Q1 2022. 342 funds tracked by Wall St. Rank hold AVNT as of Q1 2026.

  • MetLife Investment Management held 94,891 shares of Avient worth $3.44M as of Q1 2026.
  • MetLife Investment Management bought 795 Avient shares in Q1 2026, an estimated $29.5K.
  • Avient made up 0.02% of MetLife Investment Management's portfolio in Q1 2026, its #788 holding.
  • MetLife Investment Management first reported a position in Avient in Q4 2017 and has held it in 34 quarters since.
  • MetLife Investment Management's Avient position peaked at $5.06M in Q1 2022.
  • 342 funds tracked by Wall St. Rank held Avient as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.